ES2190730A1 - Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additives - Google Patents

Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additives

Info

Publication number
ES2190730A1
ES2190730A1 ES200101346A ES200101346A ES2190730A1 ES 2190730 A1 ES2190730 A1 ES 2190730A1 ES 200101346 A ES200101346 A ES 200101346A ES 200101346 A ES200101346 A ES 200101346A ES 2190730 A1 ES2190730 A1 ES 2190730A1
Authority
ES
Spain
Prior art keywords
nasal congestion
systemic
gum
pharmaceutical
ingestible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101346A
Other languages
Spanish (es)
Other versions
ES2190730B1 (en
Inventor
Ana Maria Jimenez
Antonia Gomez
Mercedes Chacon
Nuria Sanz
Laura Berges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES200101346A priority Critical patent/ES2190730B1/en
Publication of ES2190730A1 publication Critical patent/ES2190730A1/en
Application granted granted Critical
Publication of ES2190730B1 publication Critical patent/ES2190730B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical compound for systemic treatment of nasal congestion.Compound for treating nasal congestion that consists of incorporating pseudoephedrine sulphate into a chewable pharmaceutical form through which, during its ingestions, the nose is decongested in a systemic manner it incorporates as base rubber, xylitol, manitol, glycerine, maltitol syrup, acesulphame K, aspartame, pseudoephedrine sulphate, sorbitol and aromas.The systemic nasal congestion pharmaceutical comprises an ingestible product incorporating pseudo ephedrine sulfate. The product also contains base gum, xylitol, manitol, glycerine, acesulpham K, aspartam, aromas, sorbitol, and maltitol syrup.
ES200101346A 2001-06-11 2001-06-11 PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. Expired - Fee Related ES2190730B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200101346A ES2190730B1 (en) 2001-06-11 2001-06-11 PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101346A ES2190730B1 (en) 2001-06-11 2001-06-11 PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS.

Publications (2)

Publication Number Publication Date
ES2190730A1 true ES2190730A1 (en) 2003-08-01
ES2190730B1 ES2190730B1 (en) 2004-12-01

Family

ID=27675887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101346A Expired - Fee Related ES2190730B1 (en) 2001-06-11 2001-06-11 PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS.

Country Status (1)

Country Link
ES (1) ES2190730B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3389629B1 (en) * 2015-12-17 2021-04-21 Urgo Recherche Innovation et Développement Liquid composition for use as a nasal solution

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800083A (en) * 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
US5560921A (en) * 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5681577A (en) * 1993-06-04 1997-10-28 Warner-Lambert Company Multiple action cold/sinus preparations
WO2000023046A1 (en) * 1998-10-16 2000-04-27 Bush Boake Allen Inc. Chewable or dissolvable pharmaceutical compositions suitable for oral administration
WO2000056281A1 (en) * 1999-03-22 2000-09-28 Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800083A (en) * 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
US5560921A (en) * 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5681577A (en) * 1993-06-04 1997-10-28 Warner-Lambert Company Multiple action cold/sinus preparations
WO2000023046A1 (en) * 1998-10-16 2000-04-27 Bush Boake Allen Inc. Chewable or dissolvable pharmaceutical compositions suitable for oral administration
WO2000056281A1 (en) * 1999-03-22 2000-09-28 Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3389629B1 (en) * 2015-12-17 2021-04-21 Urgo Recherche Innovation et Développement Liquid composition for use as a nasal solution

Also Published As

Publication number Publication date
ES2190730B1 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
KR100511730B1 (en) Compositions having improved delivery of actives
AU770376B2 (en) Compositions having improved stability
US20060073189A1 (en) Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
WO2005020906A3 (en) Intranasal opioid compositions
NO20030915L (en) Method of anesthesia
WO2003045331A3 (en) Formulations for oral administration of cromolyn sodium
WO2005065318A3 (en) Effervescent oral opiate dosage form
WO2006100075A8 (en) Use of an artificial sweetener to enhance absorption of nicotine
PE20020694A1 (en) ORAL COMPOSITIONS THAT HAVE IMPROVED AESTHETIC CHARACTERISTICS OF THE CONSUMER
ATE374601T1 (en) MULTIPARTICULAR MEDICINAL FORM, CONTAINING MUCOADHAESIVELY FORMULATED PEPTIDE OR PROTEIN ACTIVE INGREDIENTS, AND A METHOD FOR PRODUCING THE MEDICINAL FORM
BR0308927A (en) Pleasant Chewable Tablet
GB2367005A (en) Pharmaceutical formulations and methods comprising intranasal morphine
ECSP066385A (en) MULTIVITAMIN SYRUP FOR CHILDREN OR YOUNG ADULTS
MXPA05013270A (en) Transmucosal form of administration with reduced mucosal irritation.
ES2190730A1 (en) Systemic nasal congestion pharmaceutical consists of an ingestible sulfate, gum and glycerine based mixture with additives
EP1694295B1 (en) Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
KR20010101476A (en) Compositions having improved stability
WO2003077846A3 (en) New therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
EP3087982A1 (en) Flavored analgesic and decongestant spray
GB2412865A (en) Cough mixture comprising ipecacuanha and guaifenesin
MXPA01007020A (en) Compositions having improved stability
MXPA01007015A (en) Compositions having improved delivery of actives

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030801

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2190730B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180928